Opko Health Operating Margin vs. Current Valuation
| OPK Stock | 596.00 40.40 7.27% |
For Opko Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Opko Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Opko Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Opko Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Opko Health over time as well as its relative position and ranking within its peers.
Opko |
Opko Health Current Valuation vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Opko Health's current stock value. Our valuation model uses many indicators to compare Opko Health value to that of its competitors to determine the firm's financial worth. Opko Health is considered to be number one stock in operating margin category among its peers. It also is rated top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Opko Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Opko Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Opko Current Valuation vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Opko Health |
| = | (0.20) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Opko Health |
| = | 3.9 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Opko Current Valuation vs Competition
Opko Health is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers - Specialty & Generic industry is now estimated at about 191.88 Billion. Opko Health holds roughly 3.9 Billion in current valuation claiming about 2.03% of equities under Drug Manufacturers - Specialty & Generic industry.
Opko Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Opko Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Opko Health will eventually generate negative long term returns. The profitability progress is the general direction of Opko Health's change in net profit over the period of time. It can combine multiple indicators of Opko Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida. OPKO HEALTH operates under Drug Manufacturers - Specialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 5690 people.
Opko Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Opko Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Opko Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Opko Health's important profitability drivers and their relationship over time.
Use Opko Health in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Opko Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opko Health will appreciate offsetting losses from the drop in the long position's value.Opko Health Pair Trading
Opko Health Pair Trading Analysis
The ability to find closely correlated positions to Opko Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Opko Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Opko Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Opko Health to buy it.
The correlation of Opko Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Opko Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Opko Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Opko Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Opko Health position
In addition to having Opko Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Processed Foods Thematic Idea Now
Processed Foods
Companies producing and distributing processed foods to retail sectors. The Processed Foods theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Processed Foods Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Opko Stock
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:Check out Your Equity Center. For information on how to trade Opko Stock refer to our How to Trade Opko Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
To fully project Opko Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Opko Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Opko Health's income statement, its balance sheet, and the statement of cash flows.